Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab

We report a case of Epstein-Barr virus (EBV)-driven haemophagocytic lymphohistiocytosis (HLH) in a man with Crohn's disease treated with 6-mercaptopurine and adalimumab therapy who was successfully treated with rituximab therapy alone. This is the first published case in an adult patient with EBV-driven HLH in the setting of thiopurine use and inflammatory bowel disease to be successfully treated with rituximab therapy alone. Here, we will discuss putative immunological mechanisms which may contribute to this potentially life-threatening complication.

[1]  T. Schenk,et al.  [Hemophagocytic lymphohistiocytosis in adults]. , 2016, Deutsche medizinische Wochenschrift.

[2]  E. Quigley,et al.  Features of patients with inflammatory bowel diseases who develop hemophagocytic lymphohistiocytosis , 2016, International Journal of Colorectal Disease.

[3]  A. Filipovich,et al.  Pathogenesis of Hemophagocytic Lymphohistiocytosis. , 2015, Hematology/oncology clinics of North America.

[4]  E. Quigley,et al.  Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection , 2015, Przeglad gastroenterologiczny.

[5]  M. Ninan,et al.  Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis , 2015, Case reports in oncological medicine.

[6]  M. Salamonowicz,et al.  Hemophagocytic Syndrome in Children and Adults , 2014, Archivum Immunologiae et Therapiae Experimentalis.

[7]  F. Virdis,et al.  Hemophagocytic lymphohistiocytosis caused by primary Epstein-Barr virus in patient with Crohn's disease. , 2013, World journal of gastrointestinal surgery.

[8]  M. Cottone,et al.  Systematic review: macrophage activation syndrome in inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.

[9]  R. Russell,et al.  A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab. , 2013, Journal of Crohn's & colitis.

[10]  J. Stockman.  Association of Crohn's Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis , 2013 .

[11]  R. Jaussaud,et al.  Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn's disease treated by azathioprine: a series of four cases. , 2011, Inflammatory bowel diseases.

[12]  A. Fischer,et al.  Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). , 2011, Blood.

[13]  H. Sokol,et al.  Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease. , 2009, Inflammatory bowel diseases.

[14]  J. B. Garrison,et al.  XIAP mediates NOD signaling via interaction with RIP2 , 2009, Proceedings of the National Academy of Sciences.

[15]  S. Sahasranaman,et al.  Clinical pharmacology and pharmacogenetics of thiopurines , 2008, European Journal of Clinical Pharmacology.

[16]  N. Rouphael,et al.  Infections associated with haemophagocytic syndrome , 2007, The Lancet Infectious Diseases.

[17]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[18]  Y. Berland,et al.  Tacrolimus/Mycophenolate Mofetil Improved Natural Killer Lymphocyte Reconstitution One Year After Kidney Transplant by Reference to Cyclosporine/Azathioprine , 2006, Transplantation.

[19]  M. Neurath,et al.  Both IL‐12p70 and IL‐23 are synthesized during active Crohn's disease and are down‐regulated by treatment with anti‐IL‐12 p40 monoclonal antibody , 2006, Inflammatory bowel diseases.

[20]  D. Isenberg,et al.  Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients , 2005, Clinical and experimental immunology.

[21]  H. Takada,et al.  Increased IL-16 Levels in Hemophagocytic Lymphohistiocytosis , 2004, Journal of pediatric hematology/oncology.

[22]  L. Moretta,et al.  Pathogenesis of haemophagocytic lymphohistiocytosis , 2001, British journal of haematology.

[23]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[24]  D. Winship,et al.  National Cooperative Crohn's Disease Study: study design and conduct of the study. , 1979, Gastroenterology.